EDCs |
Daphnia magna
|
Nonylphenol at 0.024 mg/L for 48 h |
Abnormal proportion of juveniles |
[119] |
Daphnia magna
|
Juvenile hormone at 330 ng/L for 21 days |
Production of male offspring |
[121] |
Ceriodaphnia dubia
|
Styrene at 0.04–1.7 μg/L for 7 days |
Mortality and reduced fertility |
[120] |
Daphnia magna
|
Bisphenol A at 6.67 and 10 mg/L for 21 days |
Reduced offspring production |
[42] |
Heavy metals |
Daphnia magna
|
Cadmium at 6, 20, and 37 μg/L for 24 h |
Reduced survival and somatic growth |
[39] |
Daphnia magna
|
Cadmium chloride at 71 μg/L for 24 h |
Increased mortality, reduced survival, depleted glutathione level, and induced oxidative stress |
[75] |
Ceriodaphnia dubia and Daphnia carinata
|
Copper, lead, zinc (at 1.3, 1.1, 13.0 mg/L, respectively) for 48 h or 7 days |
Increased mortality and reduced reproduction ability |
[123] |
Organic compounds |
Daphnia pulex
|
Organic selenium at 0.025 mg/L for 48 h |
Death, immobility, and molting delay |
[122] |
Daphnia magna
|
Propiconazole (pesticide) at 1 μg/L for 4 and 8 days |
Impaired adult growth, decreased offspring development, impaired oocyte maturation, and interrupted resulting reproduction |
[41] |
Daphnia magna
|
Fenvalerate (insecticide) at 0.6 μg/L for 24 h |
Increased mortality, reduced survival, increased arginine phosphate level, and disrupted amino sugar metabolism |
[75] |
Daphnia magna
|
Uncoupler of oxidative phosphorylation 2,4-dinitrophenol at 1.5 mg/L for 24 h |
Increased mortality, reduced survival, and increased arginine phosphate level |
[75] |
Daphnia magna
|
Alkylpolyglucosides (GCP 650, GCP 600, GCP 215) at IC50 (29, 14, 111 mg/L, respectively) for 24 h |
Increased immobility |
[124] |
Drugs |
Daphnia magna
|
Ibuprofen (non-steroidal anti-inflammatory drug or NSAID) at 20, 40, 80 mg/L for 8 days |
Reduced fecundity and arrested early embryogenesis |
[104] |
Daphnia magna
|
Beta-blocker anti-hypertension drug propanolol at 1.4 mg/L for 24 h |
Increased mortality, reduced survival, and disrupted fatty acid metabolism and eicosanoid biosynthesis |
[75] |
Daphnia magna
|
Mefenamicacid at EC50 (17.16 mg/L) for 48 h and 1 mg/L for 21 days |
Increased immobility and reduced offspring production |
[125] |
Nanoparticles |
Daphnia magna
|
Silver nanoparticles with surface coating at LC50 (0.88 μg/L) for 48 h |
Increased mortality and reduced survival |
[126] |
Daphnia magna
|
Polyvinylpyrrolidone-coated silver nanoparticles at LC50 (0.18 mg/L) for 24 h |
Increased mortality, reduced survival, disrupted proteolysis and cell cycle |
[44] |
Daphnia magna
|
Coated silver nanoparticles (Ag-GAs, Ag-PEGs, and Ag-PVPs) at LC50 (3.41, 3.16, 14.81 μg/L, respectively) for 48 h |
Increased mortality |
[127] |
Daphnia magna
|
Collargol (protein-coated nano Ag) and AgNO3 nanoparticles at EC50 (20–27 ppb) for 48 h |
Increased immobility |
[128] |
Daphnia magna
|
Ag and CuO nanoparticles at EC50 (3.8 and 2.6 mg/L, respectively) for 24 h |
Increased immobility |
[129] |
Daphnia magna
|
Titanium dioxide nanoparticles at 0.01–10 mg/L for 48 h |
Reduced survival offspring production, and digestion ability |
[130] |
Daphnia magna
|
Nano and bulk titanium dioxide at 20 g/L for 48 h |
Undetectable toxicity |
[131] |
Daphnia magna
|
Bulk CuO, nano CuO and CuSO4 at L(E)C50 (165, 3.2, 0.17 mg/L, respectively) for 48 h |
Increased immobility |
[131] |
Daphnia magna
|
Bulk ZnO, nano ZnO and ZnSO4·7H2O at L(E)C50 (1.8, 1.9, 1.1 mg/L, respectively) for 48 h |
Increased immobility |
[131] |